Inventor
BOGEN STEPHANE L
US42 patents
⚠️ This page may combine multiple inventors who share the name “BOGEN STEPHANE L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
15 patentsUS6800434B2Oct 5, 2004
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP89 citations97
US7205330B2Apr 17, 2007
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP54 citations95
US7592316B2Sep 22, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP34 citations93
US7192957B2Mar 20, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP28 citations92
US7186747B2Mar 6, 2007
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP47 citations92
US7173057B2Feb 6, 2007
Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
SCHERING CORP44 citations92
US6894072B2May 17, 2005
Compounds as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP59 citations92
US7425576B2Sep 16, 2008
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP20 citations91
US7816326B2Oct 19, 2010
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP9 citations84
US7423058B2Sep 9, 2008
Inhibitors of hepatitis C virus NS3 protease
SCHERING CORP15 citations83
US7619094B2Nov 17, 2009
Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
SCHERING CORP5 citations62
US7718691B2May 18, 2010
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP0 citations51
US7595299B2Sep 29, 2009
Peptides as NS3-serine protease inhibitors of hepatitis C virus
SCHERING CORP0 citations51
US7759499B2Jul 20, 2010
Compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP0 citations49
US7635694B2Dec 22, 2009
Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
SCHERING CORP0 citations36
MERCK SHARP & DOHME
10 patentsUS10086000B2Oct 2, 2018
Tricyclic compounds as inhibitors of mutant IDH enzymes
MERCK SHARP & DOHME3 citations71
US9732111B2Aug 15, 2017
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
MERCK SHARP & DOHME2 citations71
US11098029B2Aug 24, 2021
5-alkyl pyrrolidine orexin receptor agonists
MERCK SHARP & DOHME1 citations60
US10508108B2Dec 17, 2019
Tricyclic compounds as inhibitors of mutant IDH enzymes
MERCK SHARP & DOHME1 citations59
US9540377B2Jan 10, 2017
2,6,7,8 substituted purines as HDM2 inhibitors
MERCK SHARP & DOHME2 citations59
US8962611B2Feb 24, 2015
Substituted imidazopyridines as HDM2 inhibitors
MERCK SHARP & DOHME1 citations50
US8846657B2Sep 30, 2014
Substituted imidazopyridines as HDM2 inhibitors
MERCK SHARP & DOHME1 citations50
US10399972B2Sep 3, 2019
Tricyclic compounds as inhibitors of mutant IDH enzymes
MERCK SHARP & DOHME0 citations40
US9637493B2May 2, 2017
Substituted pyrrolopyrimidines as HDM2 inhibitors
MERCK SHARP & DOHME0 citations38
US9062071B2Jun 23, 2015
Substituted piperidines as HDM2 inhibitors
MERCK SHARP & DOHME0 citations37
MERCK SHARP & DOHME LLC
5 patentsUS12331018B2Jun 17, 2025
Pyrrolidine orexin receptor agonists
MERCK SHARP & DOHME LLC1 citations63
US12552767B2Feb 17, 2026
3-heteroaryl pyrrolidine and piperidine orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations51
US12497362B2Dec 16, 2025
Cyclopentapyrrole orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations51
US11680060B2Jun 20, 2023
Bicycloheptane pyrrolidine orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations49
US12312332B2May 27, 2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations48
DENDREON CORP
3 patentsUS7012066B2Mar 14, 2006
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP176 citations98
US7244721B2Jul 17, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP80 citations97
US7169760B2Jan 30, 2007
Peptides as NS3-serine protease inhibitors of hepatitis C virus
DENDREON CORP88 citations97